<p>PRECEDE Study Aims to Increase Early Detection in Pancreatic Cancer</p>

Global experts gather at Cornell Tech, advancing early detection and survival in pancreatic cancer fight

A recent publication in "Cancer Discovery" reviewed Germline BRCA-associated pancreatic ductal adenocarcinoma (glBRCA PDAC) spectrum of responses to platinum and PARPi therapy, exploring the genomic and clinical features that may lead to different responses, and investigates the mechanisms of resistance.

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Pancreatic Cancer

Federated learning enables collaboration without sharing data, so privacy is always protected

Dinner Gala, Fine Art Auction Slated for Saturday, March 23, will Raise Monies for Hospice Meals

Pancreatic Cancer Survivor will Serve as Special Speaker

Sheila Sky Kasselman was diagnosed with the most common form of pancreatic cancer in the fall of 2007. She completed chemotherapy, radiation and 'Whipple' surgery to remove her tumor. Nine months after her diagnosis, Sheila founded and dedicated Sky Foundation to finding an early detection for this daunting disease.

Onglyza belongs to a class of diabetes medications called DPP-4 inhibitors, FDA clinical trial data shows there may be a risk of death for some patients.

Highlands Oncology Group (HOG) has been involved in a breakthrough trial studying the effects of a combination of two medications on the treatment of refractory metastatic pancreatic cancer.

The Sandler-Kenner Foundation today announced a multiyear gift supporting a study to advance the early detection of pancreatic cancer, the fourth-leading cause of cancer death in the United States.

VIPorbit Thanks Michael Muhney and His Twitter Followers by Donating a Portion of Download Proceeds to the Hirshberg Foundation

Dr. Daniel Von Hoff, Physician-in-Chief and Distinguished Professor at Translational Genomics Research Institute (TGen) received the Scripps Genomic Medicine Award for his "pioneering efforts" in spelling out the DNA of patients with rare cancers

The TGen Foundation today joined with key donors and community leaders to announce the creation of globalCure to improve treatment and find a cure for pancreatic cancer. globalCure is an alliance between TGen and the Pancreatic Cancer Research Team.